Susquehanna International Group, LLP Graphite Bio, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	SELL	$2.47 - $3.38 $4,199 - $5,746	-1,700 Reduced 1.52%	109,800 $285,000
Q1 2023 May 16, 2023	BUY	$1.85 - $3.21 $151,700 - $263,220	82,000 Added 277.97%	111,500 $273,000
Q4 2022 Feb 14, 2023	SELL	$2.82 - $3.59 $97,290 - $123,855	-34,500 Reduced 53.91%	29,500 $97,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $4.24 $119,568 - $179,776	42,400 Added 196.3%	64,000 $203,000
Q2 2022 Aug 15, 2022	BUY	$2.14 - $5.23 $46,224 - $112,968	21,600 New	21,600 $59,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.